Your browser doesn't support javascript.
loading
Effects on α- and ß-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
Forst, Thomas; Falk, Alexander; Andersen, Grit; Fischer, Annelie; Weber, Matthias M; Voswinkel, Stephan; Heise, Tim; Kapitza, Christoph; Plum-Mörschel, Leona.
Afiliação
  • Forst T; Profil, Neuss, Germany.
  • Falk A; 1st Medical Department, Endocrinology, Johannes Gutenberg University, Mainz, Germany.
  • Andersen G; Profil, Neuss, Germany.
  • Fischer A; Profil, Neuss, Germany.
  • Weber MM; Profil, Neuss, Germany.
  • Voswinkel S; 1st Medical Department, Endocrinology, Johannes Gutenberg University, Mainz, Germany.
  • Heise T; MLM Medical Laboratories, Moenchengladbach, Germany.
  • Kapitza C; Profil, Neuss, Germany.
  • Plum-Mörschel L; Profil, Neuss, Germany.
Diabetes Obes Metab ; 19(4): 489-495, 2017 04.
Article em En | MEDLINE | ID: mdl-28009472

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Células Secretoras de Glucagon / Células Secretoras de Insulina / Linagliptina / Glucosídeos / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Células Secretoras de Glucagon / Células Secretoras de Insulina / Linagliptina / Glucosídeos / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article